Related Experiment Video
Updated: Feb 14, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
miR-16-1-3p targets TWIST1 to inhibit cell proliferation and invasion in NSCLC
Abstract:
In our study, the impact of miR-16-1-3p on cell proliferation and invasion in NSCLC was explored. miR-16-1-3p mimics were transfected to A549 cells for miR-16-1-3p overexpression. qRT- PCR and Western blot were applied to explore the relative expression of mRNA and protein in A549 cells. Furthermore, the cell proliferation capability was determined by MTT assay. Additionally, cell migration and invasion were measured using a scratch assay and transwell assay, respectively. Moreover, TargetScan and luciferase reporter assay was utilized to investigate the target of miR-16-1-3p. The results indicated that miR-16-1-3p was downregulated in NSCLC cells and upregulation of miR-16-1-3p was able to inhibit the expression of TWIST1. In addition, the reduced cell proliferation, inhibited cell migration and invasion were observed in miR-16-1-3p mimic group compared to the negative control group. The luciferase reporter gene showed that TWIST1 was a target of miR-16-1-3p. Therefore, the present study demonstrated that miR-16-1-3p may suppress A549 cell proliferation, migration and invasion by targeting TWIST1. Thus, miR-16-1-3p might play important roles in NSCLC development, which provides a novel aspect for NSCLC investigation (Fig. 6, Ref. 26).
Insights
MicroRNA-16-1-3p (miR-16-1-3p) is downregulated in non-small cell lung cancer (NSCLC). Upregulating miR-16-1-3p inhibits NSCLC cell proliferation and invasion by targeting TWIST1.
Area of Science:
- Molecular Biology
- Oncology
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality.
- Understanding the molecular mechanisms underlying NSCLC progression is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of miR-16-1-3p in NSCLC.
- To explore the regulatory relationship between miR-16-1-3p and TWIST1 in NSCLC cells.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) and Western blot analysis.
- MTT, scratch, and Transwell assays for cell proliferation, migration, and invasion.
- Luciferase reporter assay to confirm TWIST1 as a direct target of miR-16-1-3p.
Main Results:
- miR-16-1-3p expression was significantly downregulated in NSCLC cells.
- Overexpression of miR-16-1-3p inhibited A549 cell proliferation, migration, and invasion.
- TWIST1 was identified as a direct target gene of miR-16-1-3p, with miR-16-1-3p suppressing its expression.
Conclusions:
- miR-16-1-3p acts as a tumor suppressor in NSCLC by inhibiting cell proliferation and invasion.
- The miR-16-1-3p/TWIST1 axis represents a potential therapeutic target for NSCLC treatment.
- Further investigation into miR-16-1-3p's role could offer novel strategies for NSCLC management.
More Related Videos
Related Concept Videos
Cattell's 16 Personality Factors
In contrast, source traits are the...
Feedback Inhibition
Cells Coordinate Growth and Proliferation
Abnormal Proliferation
Enzyme Inhibition
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

